Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus Study

  • End date
    Jun 22, 2023
  • participants needed
  • sponsor
    National Cerebral and Cardiovascular Center
Updated on 22 January 2021
antidiabetic agents


This is the clinical trial designed to assess the cardiac diastolic function of long term treatment with teneligliptin compared to that without teneligliptin in patients with type 2 diabetes mellitus by two arms; one includes patients showing E/e' by echocardiography less than 8, the other includes patients showing E/e' by echocardiography more than 8.

Condition NIDDM, Diabetes Mellitus, Type 2, Diabetes Mellitus Type 2, type 2 diabetes mellitus, type 2 diabetes, type ii diabetes, noninsulin-dependent diabetes mellitus, diabetes type 2
Treatment Teneligliptin
Clinical Study IdentifierNCT02449330
SponsorNational Cerebral and Cardiovascular Center
Last Modified on22 January 2021


Yes No Not Sure

Inclusion Criteria

Asians aged from 20 to 85 years old at baseline
Patients with type 2 diabetes mellitus and including either A) or B) criteria
Patients necessary to start the treatment using anti-diabetic agent(s) or to change the anti-diabetic agent(s)
Patients possible to change the anti-diabetic agent(s)
Patients with left ventricular ejection fraction more than 40%
Patients with written informed consent

Exclusion Criteria

Patients with type 1 diabetes mellitus
Patients with slowly progressive type 1 diabetes mellitus positive for pancreatic islets related autoimmune antibody as GAD antibody or IA-2 antibody or ICA antibody
Patients with diabetes mellitus caused by evident genetic factors
Patients with diabetes mellitus caused by secondary factors as endocrine disease or liver disease
Patients with diabetic ketoacidosis or hyperosmolar hyperglycemic syndrome
Patients with any severe infectious diseases or planed any surgical treatments or suffered any severe traumas
Patients with severe liver dysfunction
Patients with hypophyseoprivic or adrenal insufficiency
Patients under malnutrition or starved state or irregular caloric intake or calorie insufficiency or hyposthenia
Patients judged to be unsuitable for the study as they are planning to exercise intensively
Patients judged to be unsuitable for the study as they may drink excessively or abuse drugs
Patients showing QT prolongation in the electrocardiogram
Patients with any past histories of heart failure showing NYHA classification grade more than 3 at baseline
Patients with any past histories of acute coronary syndrome or coronary intervention or cardiac surgery developed within 6 months
Patients with any surgical past histories of mitral valve replacement or mitral valve repair or severe calcification of mitral valve
Patients already treated with Teneligliptin
Women with breast-feeding
Pregnant women or patients who have possibilities of pregnancy
Patients expected to live less than 3 years
Patients with any past histories of drug hypersensitivity against Teneligliptin
Patients already involved in any other interventional clinical trials or planned to be involved
Patients judged to be inappropriate for the study by the doctors in charge
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note